| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 11,007,245 | 11,444,693 | 15,196,745 | 16,087,281 |
| Accounts receivable, net | 14,261,978 | 16,944,780 | 10,430,602 | 10,316,911 |
| Inventories, net | 5,453,836 | 6,225,518 | 2,934,723 | 3,222,872 |
| Prepaid and other current assets | 2,066,198 | 2,445,276 | 1,377,378 | 1,578,265 |
| Total current assets | 32,789,257 | 37,060,267 | 29,939,448 | 31,205,329 |
| Non-current inventories | 9,875,505 | 9,253,090 | 9,183,862 | 9,526,122 |
| Property and equipment, net | 237,375 | 264,724 | 293,375 | 297,793 |
| Intangible assets, net | 12,793,249 | 14,027,921 | 15,010,795 | 15,988,232 |
| Goodwill | 914,000 | 914,000 | 914,000 | 914,000 |
| Operating lease right-of-use assets | 7,618,720 | 8,343,832 | 7,570,452 | 7,125,408 |
| Co-commercialization investment | 3,840,700 | 3,986,780 | NaN | NaN |
| Other assets | 2,926,214 | 2,973,378 | 2,986,628 | 2,850,265 |
| Total assets | 70,995,020 | 76,823,992 | 65,898,560 | 67,907,149 |
| Current portion of revolving line of credit | NaN | NaN | 0 | 0 |
| Accounts payable | 16,537,072 | 18,567,546 | 13,832,497 | 13,446,531 |
| Operating lease current liabilities | 485,162 | 467,774 | 401,445 | 386,077 |
| Revolving line of credit - current | NaN | 0 | NaN | NaN |
| Other investment liabilities | 4,487,137 | 5,074,504 | NaN | NaN |
| Other current liabilities | 12,978,680 | 12,635,095 | 10,076,027 | 10,139,532 |
| Total current liabilities | 34,488,051 | 36,744,919 | 24,309,969 | 23,972,140 |
| Revolving line of credit - long term | 5,240,733 | 5,240,733 | 5,240,733 | 5,240,733 |
| Operating lease non-current liabilities | 4,343,892 | 4,471,965 | 4,595,768 | 4,714,183 |
| Other long-term liabilities | 5,619,332 | 5,822,153 | 5,951,386 | 6,301,166 |
| Total liabilities | 49,692,008 | 52,279,770 | 40,097,856 | 40,228,222 |
| Common stock no par value 100,000,000 shares authorized 14,983,107 and 14,956,627 shares issued and outstanding as of march 31, 2026, and december 31, 2025, respectively | 51,730,222 | 51,684,381 | 51,512,221 | 51,441,398 |
| Accumulated deficit | -30,093,698 | -26,804,059 | -25,392,367 | -23,451,603 |
| Total shareholders equity | 21,636,524 | 24,880,322 | 26,119,854 | 27,989,795 |
| Noncontrolling interests | -333,512 | -336,100 | -319,150 | -310,868 |
| Total equity | 21,303,012 | 24,544,222 | 25,800,704 | 27,678,927 |
| Total liabilities and equity | 70,995,020 | 76,823,992 | 65,898,560 | 67,907,149 |
CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC (CPIX)